JPH04103558A - Method for obtaining eicosapentaenoic acid and its ester from marine microorganism - Google Patents
Method for obtaining eicosapentaenoic acid and its ester from marine microorganismInfo
- Publication number
- JPH04103558A JPH04103558A JP21914290A JP21914290A JPH04103558A JP H04103558 A JPH04103558 A JP H04103558A JP 21914290 A JP21914290 A JP 21914290A JP 21914290 A JP21914290 A JP 21914290A JP H04103558 A JPH04103558 A JP H04103558A
- Authority
- JP
- Japan
- Prior art keywords
- epa
- ester
- fatty acid
- complex
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、エイコサペンタエン酸(以下EPAという、
)を豊富に含有する海洋微生物の脂質から、EPA及び
EPAエステルを選択的に高い濃度で得る方法に関する
。[Detailed Description of the Invention] [Industrial Application Field] The present invention provides eicosapentaenoic acid (hereinafter referred to as EPA).
The present invention relates to a method for selectively obtaining high concentrations of EPA and EPA esters from lipids of marine microorganisms rich in EPA and EPA esters.
〔従来の技術]
EPAに代表される高度不飽和脂肪酸は、高等動物に不
可欠な脂肪酸であり、生体内で重要な役割を担っている
。また、高度不飽和脂肪酸の人体に対する薬理作用も種
々知られており、特にEPAの血清脂質改善作用や抗血
栓作用等により、血栓治療薬等の医薬品としてEPAが
検討されており、EPAの高純度精製品の需要は大きい
。[Prior Art] Polyunsaturated fatty acids represented by EPA are essential fatty acids for higher animals and play an important role in living organisms. In addition, various pharmacological effects of highly unsaturated fatty acids on the human body are known, and in particular, EPA is being considered as a drug for treating blood clots due to its serum lipid-improving effect and antithrombotic effect. There is a large demand for refined products.
従来から知られている高純度EPAの製造方法としては
、魚油またはある種の微生物より抽出、精製する方法が
用いられている。EPA含有脂質の精製には、低温分別
結晶法、尿素付加法、減圧蒸留法、クロマト法等がある
が、魚油から得られたEPA含有脂質には、魚油中にE
PAの他にドコサヘキサエン酸等も含まれていることか
ら、精製過程には煩雑な操作、高価な装置を必要とする
。また微生物により生産されるEPA含有脂質は、魚油
特有の臭気はな(、その脂肪酸組成の点からは分離操作
は比較的容易であるが、微生物の培養時間が長いので生
産性の向上が大きな問題であり、また上記の各方法を用
いる精製法でも大量に安価に純度の高いEPAを分離精
製することは困難である。Conventionally known methods for producing high-purity EPA include extraction and purification from fish oil or certain types of microorganisms. EPA-containing lipids can be purified using low-temperature fractional crystallization, urea addition, vacuum distillation, chromatography, etc., but EPA-containing lipids obtained from fish oil contain E.
Since it contains docosahexaenoic acid in addition to PA, the purification process requires complicated operations and expensive equipment. In addition, EPA-containing lipids produced by microorganisms do not have the characteristic odor of fish oil (and are relatively easy to separate due to their fatty acid composition, but the long cultivation time of microorganisms makes it difficult to improve productivity). Moreover, even with the purification methods using each of the above-mentioned methods, it is difficult to separate and purify highly pure EPA in large quantities at low cost.
本発明の目的は、海洋微生物が生産するEPAを脂肪酸
混合物及び/またはEPAエステルを含む脂肪酸エステ
ル混合物に転換し、これから極めて緩和な条件で目的物
を変質させることなく、大量に安価にEPA及び/また
はEPAエステルのみを選択的に分離精製して得る方法
を提供することである。The purpose of the present invention is to convert EPA produced by marine microorganisms into a fatty acid mixture and/or a fatty acid ester mixture containing EPA ester, and from there to produce EPA and/or esters in large quantities at low cost without deteriorating the target product under extremely mild conditions. Another object of the present invention is to provide a method for selectively separating and purifying only EPA ester.
[問題を解決する手段]
本発明者等の一部は、精製が比較的容易でしかも純度の
高いEPAを得ることができ、かつ培養の時間が短くそ
の制御も容易な、EPA生産に好適なバクテリアを広く
海洋に求めた結果、特開平2−23877等において開
示しているように高度不飽和脂肪酸としてEPAのみを
生産する海洋微生物を見い出している。このような海洋
微生物は、総脂質含量が乾物換算で6〜12%と従来の
微生物によるものより高く、総脂質の脂肪酸組成は、高
度不飽和脂肪酸としてはEPAのみであり含有量も25
〜40%と高く、更に増殖速度は通常の微生物やクロレ
ラ等藻類に比べて著しく早く、多量の菌体を極めて短時
間に得ることができるという特徴を有している。これら
海洋微生物により生産されるEPAは、魚油をEPAの
供給源とした場合の安定供給性の問題点を回避すること
ができ、更に上記のような精製に容易な条件を兼ね備え
ているため、工業的規模でのEPA供給源として有利で
ある。[Means for Solving the Problems] Some of the present inventors have developed a method suitable for EPA production that is relatively easy to purify and can obtain highly pure EPA, and also has a short culture time and easy control. As a result of searching for bacteria in the ocean, we have discovered marine microorganisms that produce only EPA as a highly unsaturated fatty acid, as disclosed in Japanese Patent Application Laid-Open No. 2-23877. Such marine microorganisms have a total lipid content of 6 to 12% on a dry matter basis, which is higher than that produced by conventional microorganisms, and the fatty acid composition of the total lipid is EPA, which is the only polyunsaturated fatty acid, and the content is 25%.
The growth rate is as high as ~40%, and the growth rate is significantly faster than that of ordinary microorganisms or algae such as Chlorella, and it has the characteristic that a large amount of bacterial cells can be obtained in an extremely short period of time. EPA produced by these marine microorganisms can avoid the problems of stable supply when using fish oil as a source of EPA, and also has the conditions for easy purification as described above, making it suitable for industrial use. It is an advantageous source of EPA on a large scale.
他方また本発明者等の一部は、高度不飽和脂肪酸特にE
PA、 ドコサヘキサエン酸、アラキドン酸等に注目
して、それらを銀塩と錯体を形成させて選択的に取得す
る技術を特許画廊している(特願平2−106503)
。On the other hand, some of the inventors also believe that highly unsaturated fatty acids, especially E
Focusing on PA, docosahexaenoic acid, arachidonic acid, etc., we have patented a technology to selectively obtain them by forming complexes with silver salts (patent application 106503/1999).
.
なお一般に銀イオンは、有機化合物が不飽和結合を有す
る場合、π電子と銀イオンとが錯体な作ることが知られ
ている。この点については、特開昭63−208549
のように銀イオンを吸着剤に固定させ、銀と不飽和脂肪
酸との親和力の差を利用することにより、エイコサペン
タエン駿等の高度不飽和脂肪酸またはそのエステル体等
の誘導体を精製する方法が開示されてる。It is generally known that when an organic compound has an unsaturated bond, silver ions form a complex between π electrons and silver ions. Regarding this point, Japanese Patent Application Laid-Open No. 63-208549
Discloses a method for purifying highly unsaturated fatty acids such as eicosapentaene or derivatives such as their esters by fixing silver ions on an adsorbent and utilizing the difference in affinity between silver and unsaturated fatty acids. It's been done.
本発明はこれらの知見に基づき完成されたもので、海洋
微生物により生産されたEPAを含む脂肪酸混合物と、
不飽和炭素結合と錯体を形成する一定濃度以上の銀化合
物水溶液とを反応させて、EPAを選択的に水溶性の銀
−EPA錯体として水層に抽出し、その水層を分離して
アンモニア水等の錯体解離剤あるいは過剰の水で解離す
ることによりEPAのみを選択的に分離することを基礎
としている。本発明は、EPAのみならずEPAエステ
ルについても同様に実施することができ、メチルエステ
ル、エチルエステル等のアルキルエステルが好適に適用
されるが、特にこれに限定されるものではない。The present invention was completed based on these findings, and includes a fatty acid mixture containing EPA produced by marine microorganisms,
EPA is selectively extracted as a water-soluble silver-EPA complex into an aqueous layer by reacting an aqueous solution of a silver compound with a certain concentration or more that forms a complex with an unsaturated carbon bond, and the aqueous layer is separated and aqueous ammonia is added. It is based on selectively separating only EPA by dissociating it with a complex dissociating agent such as or with excess water. The present invention can be carried out not only with EPA but also with EPA ester, and alkyl esters such as methyl ester and ethyl ester are suitably applied, but are not particularly limited thereto.
本発明を具体的に説明すれば、本発明が適用される海洋
微生物は、EPA含量さえ高いものであれば特に属、種
あるいは株等を限定するものではないが、通常はシュー
ドモナス(Pseudomonas)属、アルテロモナ
ス (Alteromonas)属、またはシーワネラ
(Shewanel la)属等に分類される海洋微生
物である。これらのような海洋微生物が生産するEPA
含有脂質をけん化するか、または酵素を作用させて得ら
れたEPA含有脂肪酸混合物、及びエステル化して得ら
れたEPAエステル含有脂肪酸エステル混合物に、不飽
和炭素結合と錯体を形成する銀化合物の水溶液を加えて
5分〜4時間撹拌すれば、水溶性の銀−EPA及びEP
Aエステルの錯体が形成されるので、この錯体のみを他
の脂肪酸及び他の脂肪酸エステル等から選択的に分離し
て水層に溶かすことができる。EPA及びEPAエステ
ルの安定性、銀化合物の水への溶解性、錯体の生成速度
を考慮すると、反応温度は0〜100℃で行うことがで
きるが好ましくは室温付近で、反応時間は10分〜2時
間が望ましい。To specifically explain the present invention, the marine microorganism to which the present invention is applied is not particularly limited to the genus, species, or strain, as long as it has a high EPA content, but it is usually of the genus Pseudomonas. , the genus Alteromonas, or the genus Shewanel la. EPA produced by marine microorganisms such as these
An aqueous solution of a silver compound that forms a complex with an unsaturated carbon bond is added to an EPA-containing fatty acid mixture obtained by saponifying the contained lipids or by acting with an enzyme, and an EPA ester-containing fatty acid ester mixture obtained by esterification. Add water-soluble silver-EPA and EP by stirring for 5 minutes to 4 hours.
Since a complex of A ester is formed, only this complex can be selectively separated from other fatty acids and other fatty acid esters and dissolved in the aqueous layer. Considering the stability of EPA and EPA ester, the solubility of the silver compound in water, and the rate of complex formation, the reaction temperature can be carried out at 0 to 100°C, but preferably around room temperature, and the reaction time is 10 minutes to 10 minutes. 2 hours is recommended.
また、EPA及びEPAエステルの酸化安定性、銀化合
物の安定性を考慮すれば1本発明は、不活性ガス例えば
窒素雰囲気下で遮光して行うのが望ましい。不飽和炭素
結合と錯体を形成し得る銀化合物としては特に制限はな
いが一般的に言えば硝酸銀、過塩素酸銀等が好適に用い
られる。経費その他の面を考慮すれば、硝酸銀で十分で
ある。錯体を形成させるについてのEPA及びEPAエ
ステルと銀化合物とのモル比については1,30〜50
:1の範囲で、また試薬としての銀化合物水溶液の濃度
は0.1moわりから飽和水溶液の範囲で実施できる。Furthermore, in consideration of the oxidation stability of EPA and EPA ester and the stability of the silver compound, it is desirable to carry out the present invention under an inert gas atmosphere, such as nitrogen, while shielding from light. The silver compound capable of forming a complex with an unsaturated carbon bond is not particularly limited, but generally speaking, silver nitrate, silver perchlorate, etc. are preferably used. Considering cost and other aspects, silver nitrate is sufficient. The molar ratio of EPA and EPA ester to silver compound to form a complex is 1,30 to 50.
:1, and the concentration of the silver compound aqueous solution as a reagent ranges from about 0.1 mo to a saturated aqueous solution.
それ以下の濃度では銀−EPA及びEPAエステルの錯
体形成が不十分であり、EPA及びEPAエステルが水
溶性とならない。EPA及びEPAエステルの回収率を
更に考慮すると、前記のモル比は1:15〜1:1、ま
た濃度は1〜10m0ρ/I2が望ましい。If the concentration is lower than that, the complex formation of silver-EPA and EPA ester is insufficient, and EPA and EPA ester do not become water-soluble. Considering the recovery rate of EPA and EPA ester, the molar ratio is preferably 1:15 to 1:1, and the concentration is preferably 1 to 10 m0/I2.
上記で得られた錯体を含有している反応混合物中に脂溶
性の有機溶媒を加えて抽出すれば、銀と錯体を作らない
他の脂肪酸及び他の脂肪酸エステルを抽出し反応系から
除くことができる。ここで使用する有機溶媒としては、
ヘキサン、エーテル等の水に不溶の有機溶媒を用いるこ
とが好ましい。この操作で得られる水層には、銀−EP
A及びEPAエステルの錯体を含有しており、この水層
に過剰のアンモニア水等の錯体解離剤を加えるか水で希
釈することによりEPA及びEPAエステルを遊離させ
て回収することができる。銀化合物のリサイクルを考慮
すると過剰の水による希釈の方法が望ましい。錯体解離
剤の使用量、希釈する水の量は錯体を含む水層の1〜1
00倍を用いるが、好ましくは10〜40倍が望ましい
。遊離したEPA及びEPAエステルは、ヘキサン、エ
ーテル等の水に不溶の有機溶媒で柚圧し回収するが、得
られた有機層を水、飽和食塩水で洗うことにより銀イオ
ンを除くことができる。If a fat-soluble organic solvent is added to the reaction mixture containing the complex obtained above for extraction, other fatty acids and other fatty acid esters that do not form complexes with silver can be extracted and removed from the reaction system. can. The organic solvent used here is
It is preferable to use an organic solvent insoluble in water such as hexane or ether. The aqueous layer obtained by this operation contains silver-EP
It contains a complex of A and EPA ester, and by adding an excess of a complex dissociating agent such as ammonia water to this aqueous layer or diluting it with water, EPA and EPA ester can be liberated and recovered. Considering the recycling of silver compounds, it is desirable to dilute them with excess water. The amount of complex dissociating agent used and the amount of water to be diluted are 1 to 1 of the aqueous layer containing the complex.
00 times is used, but preferably 10 to 40 times. The liberated EPA and EPA ester are recovered by distillation with a water-insoluble organic solvent such as hexane or ether, and silver ions can be removed by washing the resulting organic layer with water and saturated saline.
また銀イオンを含む廃水溶液は、水を留去することで銀
化合物を回収することができ、再利用することが可能で
ある。Moreover, silver compounds can be recovered from a wastewater solution containing silver ions by distilling off water, and the wastewater solution can be reused.
また、本発明は、上記の分離精製操作を繰り返すことに
よりEPA及びEPAエステルの純度を更に上げること
が可能である。Furthermore, in the present invention, the purity of EPA and EPA ester can be further increased by repeating the above separation and purification operations.
本発明は、上に詳しく説明したように高度不飽和脂肪酸
として注目されているEPAを生産する海洋微生物が生
産するEPA含有脂肪酸混合物及び/またはEPAエス
テル含有脂肪酸エステル混合物から、まず第一に不飽和
結合と錯体を形成し得る水溶性銀化合物とEPA及び/
またばEPAエステルとの錯体を形成させ、第二にこの
錯体の水溶性を利用して選択的にEPA及び/またはE
PAエステルのみを分離し、第三に過剰のアンモニア水
等の錯体解離剤あるいは過剰の水を加え錯体を解離させ
EPA及び/またはEPAエステルを遊離させることに
より達成されるところの、海洋微生物からEPA及び/
またはそのエステルを抽出し分離して、また更に精製し
取得することができる方法である。As explained in detail above, the present invention first obtains unsaturated fatty acids from an EPA-containing fatty acid mixture and/or an EPA ester-containing fatty acid ester mixture produced by marine microorganisms that produce EPA, which is attracting attention as a highly unsaturated fatty acid. A water-soluble silver compound capable of forming a complex with the bond and EPA and/or
Alternatively, a complex with EPA ester is formed, and secondly, using the water solubility of this complex, EPA and/or E
EPA from marine microorganisms is achieved by separating only the PA ester, and then adding an excess of a complex dissociating agent such as excess aqueous ammonia or excess water to dissociate the complex and liberate EPA and/or EPA ester. as well as/
Alternatively, the ester can be extracted, separated, and further purified.
[実 施 例] 実施例により本発明を更に詳細に説明する。[Example] The present invention will be explained in more detail with reference to Examples.
実施例1
酵母エキス0.5%、ペプトン1%、NaCβ1.5%
を含有させpH7に調整した培地中で海洋微生物(アル
テロモナス・ビュートリファシエ:/ス5CRC−28
71;微工研粂寄第+gzキ号)を培養した。培養終了
後、遠心分離して菌体な集め、洗浄、乾燥して海洋微生
物菌体の粉体を得た。この粉体を乾燥した後クロロホル
ム:メタノール=2;1混合溶剤で抽出し、脂質を得た
。Example 1 Yeast extract 0.5%, peptone 1%, NaCβ 1.5%
Marine microorganisms (Alteromonas butrifaciae:/s 5CRC-28
71; Microtechnical Research Institute No. + GZ Ki No.) was cultured. After the culture was completed, the cells were collected by centrifugation, washed, and dried to obtain a powder of marine microorganism cells. After drying this powder, it was extracted with a mixed solvent of chloroform:methanol=2:1 to obtain a lipid.
脂質を減圧蒸留して溶剤を除いて得られた総脂質を0.
3N−NaOHを含有する95%エタノール中で80℃
にて1時聞けん化した後、これを6N−HClで中和し
、遊離脂肪酸混合物を生成させた。この脂肪酸混合物を
ジアゾメタンによりメチルエステル化した後、ガスクロ
マトグラフにて分析したところ、EPAが全脂肪酸中に
18.5%含まれていた。The total lipid obtained by distilling the lipid under reduced pressure and removing the solvent is 0.
80°C in 95% ethanol containing 3N-NaOH
After saponifying the mixture for 1 hour, it was neutralized with 6N-HCl to produce a free fatty acid mixture. After methyl esterifying this fatty acid mixture with diazomethane, analysis using a gas chromatograph revealed that 18.5% of EPA was contained in the total fatty acids.
この脂肪酸混合物2.0602gをヘキサン1.5mj
2に溶かしてヘキサン溶液とし、これに硝酸銀2.50
54gを蒸留水1.5m℃に溶がした水溶液を、窒素雰
囲気遮光下で加えて2時間撹拌した。撹拌終了後、反応
液をヘキサン40mj2で2回洗浄した。残った水層に
蒸留水4゜mβを加え、1時間撹拌し、錯体を生成させ
た脂肪酸を遊離させた。遊離した脂肪酸をヘキサン40
rnβで2回抽出し、得られたヘキサン層を合一して蒸
留水、飽和食塩水で洗い、硫酸マグネシウムで脱水した
。脂肪酸を溶解しているヘキサン溶液を減圧下濃縮して
、131.1mgの脂肪酸を得た。ジアゾメタンにより
得られた脂肪酸をメチルエステル化した後、ガスクロマ
トグラフにて分析したところ、EPAの純度が94.9
%(全脂肪酸中)であった。2.0602g of this fatty acid mixture was mixed with 1.5mj of hexane.
2 to make a hexane solution, and add 2.50 g of silver nitrate to this.
An aqueous solution prepared by dissolving 54 g of distilled water at 1.5 m° C. was added under nitrogen atmosphere and shielded from light, and the mixture was stirred for 2 hours. After the stirring was completed, the reaction solution was washed twice with 40 mj2 of hexane. Distilled water 4°mβ was added to the remaining aqueous layer and stirred for 1 hour to liberate the complexed fatty acids. The free fatty acids are converted into hexane 40
Extraction was carried out twice with rnβ, and the obtained hexane layers were combined, washed with distilled water and saturated saline, and dehydrated with magnesium sulfate. The hexane solution in which fatty acids were dissolved was concentrated under reduced pressure to obtain 131.1 mg of fatty acids. After methyl esterifying the fatty acid obtained with diazomethane, analysis using a gas chromatograph revealed that the purity of EPA was 94.9.
% (of total fatty acids).
実施例2
脂肪酸メチルエステル混合物を用いて錯体を形成させる
本発明の方法の例である。Example 2 is an example of the method of the present invention in which a fatty acid methyl ester mixture is used to form a complex.
実施例1で用いた抽出脂質なジアゾメタンを用いる常法
によりメチルエステル化して脂肪酸メチルエステル混合
物を得た。この脂肪酸メチルニス輌
チル混合物を、ガスクロマトグラフで分析したところ、
EPAメチルエステルが18.7%(全脂肪酸メチルエ
ステル中)含まれていた。Methyl esterification was carried out by a conventional method using diazomethane, the extracted lipid used in Example 1, to obtain a fatty acid methyl ester mixture. When this fatty acid methyl varnish mixture was analyzed by gas chromatography, it was found that
It contained 18.7% (of all fatty acid methyl esters) of EPA methyl ester.
得られた脂肪酸メチルエステル混合物
2.1063gをヘキサン1.5mでに溶かしてヘキサ
ン溶液とし、これに硝酸銀2.5087gを蒸留水1.
5mJ2に溶かした水溶液を用いて実施例1で述べたと
全く同じ操作を行って錯体の形成、解離の後、脂肪酸メ
チルエステル混合物140.3mgを得た。これをガス
クロマトグラフにて分析したところ、EPAメチルエス
テルの純度が94.0%であった。2.1063 g of the obtained fatty acid methyl ester mixture was dissolved in 1.5 m of hexane to obtain a hexane solution, and 2.5087 g of silver nitrate was added to 1.5 m of distilled water.
Exactly the same operation as described in Example 1 was performed using an aqueous solution dissolved in 5 mJ2, and after formation and dissociation of a complex, 140.3 mg of a fatty acid methyl ester mixture was obtained. When this was analyzed by gas chromatography, the purity of EPA methyl ester was 94.0%.
実施例3
ペプトン2%、酵母エキス0.5%を含む海水培地(p
H7,0)で海洋微生物(シュードモナス・ビュートリ
ファシェンス5CRC−2878;微工研条寄第162
3号)を培養した。培養終了後、遠心分離して菌体を集
めクロロホルム、メタノール=2=1混合溶剤で抽出し
た。抽出後減圧濃縮して溶剤を除いて得られた総脂質を
、ナトリウムエチラートを使用する常法によりエチルエ
ステル化し脂肪酸エチルエステル混合物を得た。Example 3 Seawater medium containing 2% peptone and 0.5% yeast extract (p
H7,0) and marine microorganisms (Pseudomonas buterifaciens 5CRC-2878;
No. 3) was cultured. After the culture was completed, the cells were collected by centrifugation and extracted with a mixed solvent of chloroform and methanol (2=1). After extraction, the mixture was concentrated under reduced pressure to remove the solvent, and the resulting total lipids were ethyl esterified by a conventional method using sodium ethylate to obtain a fatty acid ethyl ester mixture.
この脂肪酸エチルエステル混合物をガスクロマトグラフ
で分析したところ、EPAエチルエステルが20.6%
(全脂肪酸エチルエステル中)含まれていた。When this fatty acid ethyl ester mixture was analyzed by gas chromatography, it was found that EPA ethyl ester was 20.6%.
(in total fatty acid ethyl esters).
得られた脂肪酸エチルエステル混合物
4.2653gをヘキサン3.0mAに溶かしてヘキサ
ン溶液とし、これに硝酸銀5.0865gを蒸留水3.
0mf2に溶かした水溶液を用いて実施例1で述べたと
全く同じ操作を行って錯体の形成、解離の後、脂肪酸エ
チルエステル混合物368.8mgを得た。これをガス
クロマトグラフで分析したところ、EPAエチルエステ
ルの純度が96.3%であった。4.2653 g of the obtained fatty acid ethyl ester mixture was dissolved in 3.0 mA of hexane to obtain a hexane solution, and 5.0865 g of silver nitrate was added to 3.0 mA of distilled water.
Exactly the same operation as described in Example 1 was performed using an aqueous solution dissolved in 0 mf2, and after formation and dissociation of a complex, 368.8 mg of a fatty acid ethyl ester mixture was obtained. When this was analyzed by gas chromatography, the purity of EPA ethyl ester was 96.3%.
実施例4
ペプトン3%、酵母エキス0.5%を含む海水培地(p
H7,0)で海洋微生物(シーワネラ・ビュートリファ
シェンス5CRC−2874、微工研条寄第1625号
)を培養した。培養終了後、遠心分離して菌体を集めク
ロロホルム:メタノール=2:l混合溶剤で抽出した。Example 4 A seawater medium containing 3% peptone and 0.5% yeast extract (p
Marine microorganisms (Seawanella buterifaciens 5CRC-2874, Kaikoken Jokyo No. 1625) were cultured in the microorganisms (H7,0). After the culture was completed, the cells were collected by centrifugation and extracted with a mixed solvent of chloroform:methanol=2:l.
抽出後減圧濃縮して溶剤を除いて得られた総脂質を、ナ
トリウムエチラートを使用する常法によりエチルエステ
ル化し脂肪酸エチルエステル混合物を得た。この脂肪酸
エチルエステル混合物をガスクロマトグラフで分析した
ところ、EPAエチルエステルが18.3%(全脂肪酸
エチルエステル中)含まれていた。After extraction, the mixture was concentrated under reduced pressure to remove the solvent, and the resulting total lipids were ethyl esterified by a conventional method using sodium ethylate to obtain a fatty acid ethyl ester mixture. When this fatty acid ethyl ester mixture was analyzed by gas chromatography, it was found that it contained 18.3% (of all fatty acid ethyl esters) of EPA ethyl ester.
得られた脂肪酸エチルエステル混合物
6.5148gをヘキサン4.5m℃に溶かしてヘキサ
ン溶液とし、これに硝酸銀8.6513gを蒸留水4.
5mgに溶かした水溶液を用いて実施例1で述べたと全
く同じ操作を行って錯体の形成、解離の後、脂肪酸エチ
ルエステル混合物589.4mgを得た。これをガスク
ロマトグラフで分析したところ、EPAエチルエステル
の純度が95.6%であった。6.5148 g of the obtained fatty acid ethyl ester mixture was dissolved in hexane at 4.5 m°C to obtain a hexane solution, and 8.6513 g of silver nitrate was added to 4.5 m C of distilled water.
Exactly the same operation as described in Example 1 was carried out using an aqueous solution containing 5 mg of the fatty acid ethyl ester, and after formation and dissociation of a complex, 589.4 mg of a fatty acid ethyl ester mixture was obtained. When this was analyzed by gas chromatography, the purity of EPA ethyl ester was 95.6%.
[発明の効果〕
本発明の方法によれば、従来の方法とは著しく異なりほ
ぼ常温で、操作、設備も簡単なうえ、低コストで海洋微
生物が生産する、魚臭のないEPA及び/またはEPA
エステルを容易に選択的に得ることができる。[Effects of the Invention] The method of the present invention is significantly different from conventional methods in that it produces EPA and/or EPA without fishy odor, which is produced by marine microorganisms at almost room temperature, with simple operation and equipment, and at low cost.
Esters can be easily and selectively obtained.
Claims (2)
れる脂肪酸混合物及び/またはエステル交換反応を行っ
て得られる脂肪酸エステル混合物を水性媒体中で銀塩と
接触させて錯体を形成させ、その後錯体解離剤を加える
ことを特徴とする、海洋微生物からエイコサペンタエン
酸及び/またはそのエステルを得る方法。(1) Extract lipids from marine microbial cells, bring the resulting fatty acid mixture and/or the fatty acid ester mixture obtained by transesterification into contact with a silver salt in an aqueous medium to form a complex, and then A method for obtaining eicosapentaenoic acid and/or its ester from marine microorganisms, which comprises adding a complex dissociating agent.
1に記載の方法。(2) The method according to claim 1, wherein the concentration of the silver salt is 0.1 mol/l or more.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21914290A JPH04103558A (en) | 1990-08-22 | 1990-08-22 | Method for obtaining eicosapentaenoic acid and its ester from marine microorganism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21914290A JPH04103558A (en) | 1990-08-22 | 1990-08-22 | Method for obtaining eicosapentaenoic acid and its ester from marine microorganism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH04103558A true JPH04103558A (en) | 1992-04-06 |
Family
ID=16730880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21914290A Pending JPH04103558A (en) | 1990-08-22 | 1990-08-22 | Method for obtaining eicosapentaenoic acid and its ester from marine microorganism |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH04103558A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015091940A (en) * | 2013-09-30 | 2015-05-14 | 日清ファルマ株式会社 | Method for producing eicosapentaenoic acid and / or docosahexaenoic acid-containing composition |
| WO2015129190A1 (en) * | 2014-02-28 | 2015-09-03 | 備前化成株式会社 | Method for purifying stearidonic acid |
-
1990
- 1990-08-22 JP JP21914290A patent/JPH04103558A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015091940A (en) * | 2013-09-30 | 2015-05-14 | 日清ファルマ株式会社 | Method for producing eicosapentaenoic acid and / or docosahexaenoic acid-containing composition |
| WO2015129190A1 (en) * | 2014-02-28 | 2015-09-03 | 備前化成株式会社 | Method for purifying stearidonic acid |
| JPWO2015129190A1 (en) * | 2014-02-28 | 2017-03-30 | 備前化成株式会社 | Method for purifying stearidonic acid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6312290A (en) | Production of lipid containing arachidonic acid | |
| JPS6262155B2 (en) | ||
| JPH0595792A (en) | Production of oil and fat containing concentrated highly unsaturated fatty acid | |
| IE60284B1 (en) | "Process for the preparation of 2-arylpropionic acids" | |
| JPH04218596A (en) | Selective acquisition of highly unsaturated fatty acids | |
| JP3001954B2 (en) | How to obtain polyunsaturated fatty acids | |
| JPS5933354B2 (en) | Production method of coenzyme Q | |
| JPH04103558A (en) | Method for obtaining eicosapentaenoic acid and its ester from marine microorganism | |
| JPH04243849A (en) | Purification of highly unsaturated fatty acid and its derivative | |
| JPH05308978A (en) | Method for producing docosahexaenoic acid by algae | |
| JPH01199588A (en) | Production of highly unsaturated aliphatic acid with filamentous fungus | |
| JPH01228486A (en) | Highly unsaturated fatty acid having chain of odd carbon number and production of lipid containing said acid | |
| JPH05276963A (en) | Production of docosahexaenoic acid | |
| JP2001505581A (en) | Method for recovering ascorbic acid | |
| JPH107618A (en) | Production of eicosapentaenoic acid ester | |
| JP3880095B2 (en) | Method for purifying highly unsaturated fatty acids | |
| JP2718650B2 (en) | Method for producing highly unsaturated fatty acid alcohol ester | |
| JP4081794B2 (en) | Novel Labyrinthula microorganism and method for producing 4,7,10,13,16-docosapentaenoic acid using the same | |
| JPS6337B2 (en) | ||
| JPS63295527A (en) | Method for concentrating and separating highly unsaturated fatty acid | |
| JP3719732B2 (en) | Process for producing highly unsaturated fatty acid glycerides | |
| JP3477512B2 (en) | Method for producing polyunsaturated fatty acids using microorganisms | |
| JPH0349688A (en) | Preparation of dihomo-gamma-linolenic acid and agent for inhibiting delta5-position unsaturation reaction of fatty acid | |
| JPH10139718A (en) | Method for producing eicosapentaenoic acid | |
| JPS639838B2 (en) |